Traci S. Umberger, the General Counsel and Chief Administrative Officer of Kestra Medical Technologies, has made notable stock transactions that could indicate her confidence in the company’s future. The transactions, reported in a recent SEC filing, include both the acquisition and sale of shares. This activity is significant as it reflects broader trends in the surgical and medical instruments industry.

Company Background

Kestra Medical Technologies, Inc., identified by CIK 0001877184, operates within the surgical and medical instruments and apparatus sector. The company is based in Kirkland, Washington, and has been active in filing various reports with the SEC, including recent filings on October 29, 2026, and October 22, 2026.

What the Filing Says

The SEC filing, accession number 0001193125-26-438662, details Umberger's transactions on October 27, 2026. She acquired 30,000 shares of common stock at a price of $17.00 per share and sold 30,000 shares at a weighted average price of $30.0294, with the sale price ranging from $30.0000 to $30.4202. Following these transactions, Umberger holds a total of 195,825 shares of common stock and 411,000 shares when including options.

Impact

These transactions may affect various stakeholders, including shareholders and potential investors, as they reflect Umberger's personal investment strategy and confidence in the company's prospects. The surgical and medical instruments industry may also observe these activities closely, as they could influence market perceptions and competitive strategies.

What's Next

The filing does not say what happens next.